CrowdStrike Holdings, Inc. R&D increased by 2.5% to $356.41M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 654.7%, from $47.23M to $356.41M. Over 4 years (FY 2022 to FY 2026), R&D shows an upward trend with a 39.0% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ3 2018
Last reportedQ4 2026Mar 5, 2026
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
Metric ID:
research_and_developmentHistorical Data
20 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $78.18M | $90.46M | $97.63M | $105.02M | $123.40M | $137.86M | $155.26M | $53.87M | $179.07M | $179.36M | $196.07M | $18.56M | $235.25M | $250.91M | $275.60M | $47.23M | $334.13M | $346.67M | $347.56M | $356.41M |
| QoQ Change | — | +15.7% | +7.9% | +7.6% | +17.5% | +11.7% | +12.6% | -65.3% | +232.4% | +0.2% | +9.3% | -90.5% | >999% | +6.7% | +9.8% | -82.9% | +607.5% | +3.8% | +0.3% | +2.5% |
| YoY Change | — | — | — | — | +57.8% | +52.4% | +59.0% | -48.7% | +45.1% | +30.1% | +26.3% | -65.5% | +31.4% | +39.9% | +40.6% | +154.5% | +42.0% | +38.2% | +26.1% | +654.7% |
Range$18.56M – $356.41M
CAGR+37.6%
Avg YoY Growth+74.0%
Median YoY Growth+40.2%
Current Streak4 quarters growth
R&D at Other Companies
Frequently Asked Questions
- What is CrowdStrike Holdings, Inc.'s r&d?
- CrowdStrike Holdings, Inc. (CRWD) reported r&d of $356.41M in Q4 2025.
- How has CrowdStrike Holdings, Inc.'s r&d changed year-over-year?
- CrowdStrike Holdings, Inc.'s r&d increased by 654.7% year-over-year, from $47.23M to $356.41M.
- What is the long-term trend for CrowdStrike Holdings, Inc.'s r&d?
- Over 4 years (2022 to 2026), CrowdStrike Holdings, Inc.'s r&d has grown at a 39.0% compound annual growth rate (CAGR), from $371.28M to $1.38B.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.